Dr Emma Haapaniemi joined NCMM as a group leader in January 2019. Her research programme will focus on rare immune diseases caused by genetics and rare acquired autoimmune diseases.
Professor Janna Saarela joined NCMM as Director in January 2019. She was previously head of the Technology Centre and Deputy Director of the Institute for Molecular Medicine Finland (FIMM), which is also part of the Nordic EMBL Partnership. Here she shares some insight into her research, and what she hopes the future holds for NCMM.
- NCMM seeks Group Leader in Precision Medicine July 8, 2019 3:31 PM
- Roadmap for a precision-medicine initiative in the Nordic region. June 24, 2019 10:01 AM
- Horizon2020 grant for NCMM Assistant Director June 21, 2019 9:21 AM